-
EP4273168
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4273168
| EP4273168 - ANTIBODY THAT SPECIFICALLY BINDS TO BCMA AND APPLICATION THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 06.10.2023 Database last updated on 19.10.2024 | |
| Former | The international publication has been made Status updated on 09.07.2022 | Most recent event Tooltip | 01.03.2024 | Change: Validation states | published on 03.04.2024 [2024/14] | 01.03.2024 | Change - extension states | published on 03.04.2024 [2024/14] | Applicant(s) | For all designated states Beijing Immunochina Pharmaceuticals Co., Ltd. No. 316, 3rd Floor, Bldg 1, Area B Yiyuan Cultural And Creative Industry Base No. 80, Xingshikou Road Haidian District Beijing 100195 / CN | For all designated states Beijing Yimiaoyiliao Co., Ltd. 4th Floor, Building 2, Yard 16 Baocan South Street Daxing Bio-Pharmaceutical Industrial Base Zhongguancun Science Park, Daxing District Beijing 102629 / CN | [2023/45] | Inventor(s) | 01 /
LU, Xinan Beijing 100195 / CN | 02 /
HE, Ting Beijing 100195 / CN | 03 /
QI, Feifei Beijing 100195 / CN | 04 /
DING, Yanping Beijing 100195 / CN | 05 /
LIU, Guanghua Beijing 100195 / CN | 06 /
HU, Xuelian Beijing 100195 / CN | 07 /
XU, Wenping Beijing 100195 / CN | [2023/45] | Representative(s) | Dolphin, Kirsty Mairi Venner Shipley LLP 200 Aldersgate London EC1A 4HD / GB | [2023/45] | Application number, filing date | 21914601.6 | 30.12.2021 | [2023/45] | WO2021CN142886 | Priority number, date | CN202011633936 | 31.12.2020 Original published format: CN202011633936 | [2023/45] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022143870 | Date: | 07.07.2022 | Language: | ZH | [2022/27] | Type: | A1 Application with search report | No.: | EP4273168 | Date: | 08.11.2023 | Language: | EN | [2023/45] | Search report(s) | International search report - published on: | CN | 07.07.2022 | Classification | IPC: | C07K16/28, C07K19/00, C12N15/13, C12N15/62, C12N5/10, A61K39/00, A61K35/17, A61P35/00, A61P35/02, A61P37/02, A61P31/04, A61P31/12 | [2023/45] | CPC: |
C07K16/2878 (EP,CN,US);
A61K35/17 (CN);
A61K39/00 (CN);
A61K39/4611 (EP,US);
A61K39/4631 (EP,US);
A61K39/464411 (US);
A61K39/464417 (EP);
A61P31/04 (CN);
A61P31/12 (CN);
A61P35/00 (CN);
A61P35/02 (CN);
A61P37/02 (CN);
C07K14/7051 (CN,US);
C07K14/70521 (US);
C07K14/70578 (EP,US);
A61K2239/13 (EP,US);
C07K2317/56 (CN);
C07K2317/565 (CN);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/45] | Title | German: | SPEZIFISCH AN BCMA BINDENDER ANTIKÖRPER UND ANWENDUNG DAVON | [2023/45] | English: | ANTIBODY THAT SPECIFICALLY BINDS TO BCMA AND APPLICATION THEREOF | [2023/45] | French: | ANTICORPS SE LIANT DE MANIÈRE SPÉCIFIQUE À UN ANTIGÈNE DE MATURATION DES CELLULES B ET SON APPLICATION | [2023/45] | Entry into regional phase | 18.07.2023 | Translation filed | 18.07.2023 | National basic fee paid | 18.07.2023 | Search fee paid | 18.07.2023 | Designation fee(s) paid | 18.07.2023 | Examination fee paid | Examination procedure | 18.07.2023 | Amendment by applicant (claims and/or description) | 18.07.2023 | Examination requested [2023/45] | Fees paid | Renewal fee | 19.12.2023 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | |||